Globus Medical Inc (NYSE: GMED)

Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The firm is dedicated to improving patient quality of life through innovative products and surgeon focused development. It maintains an engineering driven culture that enables rapid introduction of new technologies. Globus Medical, Inc. offers a broad portfolio spanning implantable devices, biologics, surgical instruments, spinal cord stimulation systems, neuromonitoring services and enabling technologies such as imaging navigation and robotics platforms. The company operates in over 65 countries and launched 9 new products in 2025.

The company generates revenue primarily through the sale of its medical devices and related services to hospitals ambulatory surgery centers and physicians. Sales are conducted via a direct sales force and through exclusive independent distributors who receive a commission based on a percentage of sales. Revenue streams include product sales of implantable devices biologics spinal cord stimulation systems and neuromonitoring services as well as service income from equipment leasing and technician support. In the year ended December 31 2025 international sales represented approximately 19.4% of total revenue while the remainder came from the United States.

The company operates through the following segments.

• Musculoskeletal Solutions: This segment includes implantable devices for spinal orthopedic and neurosurgical procedures such as pedicle screw systems interbody spacers and vertebral body replacement options. It also provides biologics including allografts and synthetic bone graft substitutes that are used alongside hardware to promote fusion. Additionally the segment offers surgical instruments spinal cord stimulation systems for chronic pain management and neuromonitoring services that assist surgeons during operations.

• Enabling Technologies: This segment comprises imaging navigation and robotics systems such as the ExcelsiusGPS robotic guidance platform which supports minimally invasive and open screw placement. It also includes the Surgimap surgical planning software that enables preoperative simulation and the Excelsius3D imaging module that provides intra operative visualization. Additional products are the ExcelsiusHub and ExcelsiusFlex accessories and the ExcelsiusXR extended reality headset designed to improve surgical accuracy and reduce radiation exposure.

Globus Medical, Inc. holds a competitive position in the medical device industry alongside major rivals such as Medtronic DePuy Synthes Stryker Zimmer Biomet and Smith & Nephew as well as Alphatec Holdings Orthofix Integra LifeSciences ZimVie VB Spine and Boston Scientific. The company differentiates itself through an engineering driven approach rapid product development cycles and close collaboration with surgeons to introduce innovative solutions. Its diversified portfolio across musculoskeletal solutions and enabling technologies allows it to address a broad range of patient needs and capture opportunities in adjacent markets. Furthermore the firm leverages its global sales force and surgeon education programs to strengthen customer loyalty and maintain market share.

The company serves hospitals ambulatory surgery centers and physicians who perform spinal orthopedic and neurosurgical procedures. Its customer base also includes academic medical centers research institutions and specialty clinics that focus on spine orthopedics and neurosurgery. Geographically the majority of revenue comes from the United States with a growing presence in Europe, Asia Pacific, and Latin America. While specific customer names are not disclosed in the filing the firm emphasizes long term partnerships with health care providers to support procedural volume and product adoption.